Fibronectin bridges monocytes and reticulocytes via integrin α4β1

Julia Elizabeth Brittain, Christine M. Knoll, Kenneth I. Ataga, Eugene P. Orringer, Leslie V. Parise

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Leucocytes are emerging as critical determinants in the severity of the pathology associated with sickle cell disease (SCD) and recent studies have shown that they can bind to sickle red blood cells (SS RBCs). However, the mechanism of this interaction is unclear. The α4β1 integrin on monocytes and SS reticulocytes was found to mediate the interaction of these cells in in-vitro adhesion assays and in the blood of SCD patients. Plasma fibronectin (Fn), a ligand for α4β1, could link SS RBCs to monocytes, as peptides derived from both the Arg-Gly-Asp-Ser (RGDS) and CS-1 site in Fn disrupted the reticulocyte/monocyte interaction. It was further shown in whole blood that 70% of the interacting monocytes were also bound to platelets, suggesting the existence of multi-cellular aggregates in SCD. Platelet inclusion in these aggregates was mediated by a P-selectin/P-selectin glycoprotein ligand-1 interaction, which has been demonstrated to activate the monocyte. These results suggest a new model for understanding the mechanism of attachment of SS RBCs to monocytes and implicate the platelet as a component and contributor to potentially occlusive aggregates that circulate in the blood of SCD patients.

Original languageEnglish (US)
Pages (from-to)872-881
Number of pages10
JournalBritish Journal of Haematology
Volume141
Issue number6
DOIs
StatePublished - Jun 1 2008

Fingerprint

Reticulocytes
Fibronectins
Integrins
Monocytes
Sickle Cell Anemia
Blood Platelets
Blood Cells
arginyl-glycyl-aspartyl-serine
P-Selectin
Cell Communication
Leukocytes
Erythrocytes
Pathology
Ligands
Peptides

Keywords

  • Adhesion
  • Integrin
  • Leucocyte
  • Reticulocyte
  • Sickle

ASJC Scopus subject areas

  • Hematology

Cite this

Brittain, J. E., Knoll, C. M., Ataga, K. I., Orringer, E. P., & Parise, L. V. (2008). Fibronectin bridges monocytes and reticulocytes via integrin α4β1. British Journal of Haematology, 141(6), 872-881. https://doi.org/10.1111/j.1365-2141.2008.07056.x

Fibronectin bridges monocytes and reticulocytes via integrin α4β1. / Brittain, Julia Elizabeth; Knoll, Christine M.; Ataga, Kenneth I.; Orringer, Eugene P.; Parise, Leslie V.

In: British Journal of Haematology, Vol. 141, No. 6, 01.06.2008, p. 872-881.

Research output: Contribution to journalArticle

Brittain, JE, Knoll, CM, Ataga, KI, Orringer, EP & Parise, LV 2008, 'Fibronectin bridges monocytes and reticulocytes via integrin α4β1', British Journal of Haematology, vol. 141, no. 6, pp. 872-881. https://doi.org/10.1111/j.1365-2141.2008.07056.x
Brittain, Julia Elizabeth ; Knoll, Christine M. ; Ataga, Kenneth I. ; Orringer, Eugene P. ; Parise, Leslie V. / Fibronectin bridges monocytes and reticulocytes via integrin α4β1. In: British Journal of Haematology. 2008 ; Vol. 141, No. 6. pp. 872-881.
@article{84a717cd10ac42d595df1d294b964978,
title = "Fibronectin bridges monocytes and reticulocytes via integrin α4β1",
abstract = "Leucocytes are emerging as critical determinants in the severity of the pathology associated with sickle cell disease (SCD) and recent studies have shown that they can bind to sickle red blood cells (SS RBCs). However, the mechanism of this interaction is unclear. The α4β1 integrin on monocytes and SS reticulocytes was found to mediate the interaction of these cells in in-vitro adhesion assays and in the blood of SCD patients. Plasma fibronectin (Fn), a ligand for α4β1, could link SS RBCs to monocytes, as peptides derived from both the Arg-Gly-Asp-Ser (RGDS) and CS-1 site in Fn disrupted the reticulocyte/monocyte interaction. It was further shown in whole blood that 70{\%} of the interacting monocytes were also bound to platelets, suggesting the existence of multi-cellular aggregates in SCD. Platelet inclusion in these aggregates was mediated by a P-selectin/P-selectin glycoprotein ligand-1 interaction, which has been demonstrated to activate the monocyte. These results suggest a new model for understanding the mechanism of attachment of SS RBCs to monocytes and implicate the platelet as a component and contributor to potentially occlusive aggregates that circulate in the blood of SCD patients.",
keywords = "Adhesion, Integrin, Leucocyte, Reticulocyte, Sickle",
author = "Brittain, {Julia Elizabeth} and Knoll, {Christine M.} and Ataga, {Kenneth I.} and Orringer, {Eugene P.} and Parise, {Leslie V.}",
year = "2008",
month = "6",
day = "1",
doi = "10.1111/j.1365-2141.2008.07056.x",
language = "English (US)",
volume = "141",
pages = "872--881",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Fibronectin bridges monocytes and reticulocytes via integrin α4β1

AU - Brittain, Julia Elizabeth

AU - Knoll, Christine M.

AU - Ataga, Kenneth I.

AU - Orringer, Eugene P.

AU - Parise, Leslie V.

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Leucocytes are emerging as critical determinants in the severity of the pathology associated with sickle cell disease (SCD) and recent studies have shown that they can bind to sickle red blood cells (SS RBCs). However, the mechanism of this interaction is unclear. The α4β1 integrin on monocytes and SS reticulocytes was found to mediate the interaction of these cells in in-vitro adhesion assays and in the blood of SCD patients. Plasma fibronectin (Fn), a ligand for α4β1, could link SS RBCs to monocytes, as peptides derived from both the Arg-Gly-Asp-Ser (RGDS) and CS-1 site in Fn disrupted the reticulocyte/monocyte interaction. It was further shown in whole blood that 70% of the interacting monocytes were also bound to platelets, suggesting the existence of multi-cellular aggregates in SCD. Platelet inclusion in these aggregates was mediated by a P-selectin/P-selectin glycoprotein ligand-1 interaction, which has been demonstrated to activate the monocyte. These results suggest a new model for understanding the mechanism of attachment of SS RBCs to monocytes and implicate the platelet as a component and contributor to potentially occlusive aggregates that circulate in the blood of SCD patients.

AB - Leucocytes are emerging as critical determinants in the severity of the pathology associated with sickle cell disease (SCD) and recent studies have shown that they can bind to sickle red blood cells (SS RBCs). However, the mechanism of this interaction is unclear. The α4β1 integrin on monocytes and SS reticulocytes was found to mediate the interaction of these cells in in-vitro adhesion assays and in the blood of SCD patients. Plasma fibronectin (Fn), a ligand for α4β1, could link SS RBCs to monocytes, as peptides derived from both the Arg-Gly-Asp-Ser (RGDS) and CS-1 site in Fn disrupted the reticulocyte/monocyte interaction. It was further shown in whole blood that 70% of the interacting monocytes were also bound to platelets, suggesting the existence of multi-cellular aggregates in SCD. Platelet inclusion in these aggregates was mediated by a P-selectin/P-selectin glycoprotein ligand-1 interaction, which has been demonstrated to activate the monocyte. These results suggest a new model for understanding the mechanism of attachment of SS RBCs to monocytes and implicate the platelet as a component and contributor to potentially occlusive aggregates that circulate in the blood of SCD patients.

KW - Adhesion

KW - Integrin

KW - Leucocyte

KW - Reticulocyte

KW - Sickle

UR - http://www.scopus.com/inward/record.url?scp=44249109503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44249109503&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2008.07056.x

DO - 10.1111/j.1365-2141.2008.07056.x

M3 - Article

VL - 141

SP - 872

EP - 881

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 6

ER -